ClinConnect ClinConnect Logo

Main Menu

Search for Trials
For HCPs
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up
Search / Trial NCT06900946

Evaluation of the Effects of Gluten Free Diet on Clinical Symptoms and Glycemic Index in Type 2 Diabetic Patients with Non-celiac Gluten Sensitivity

Launched by NATIONAL NUTRITION AND FOOD TECHNOLOGY INSTITUTE · Mar 22, 2025

Download PDF Apply for Trial

Trial Information

Current as of April 22, 2025

Not yet recruiting

Keywords

Type 2 Diabetes T2 Dm Ncgs Non Celiac Gluten Sensitivity Gluten Free Diet Gfd

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Exclusion of Celiac Disease and Wheat Allergy (tTG IgA antibody test for celiac disease exclusion and IgE antibody test for ruling out wheat allergy)
  • • Exclusion of Irritable Bowel Syndrome (IBS) using the Rome IV diagnostic criteria by a gastroenterologist
  • • No adherence to any specific diet in the past 6 months, including the gluten-free diet (GFD)
  • • Willing and capable of following a gluten-free diet (GFD)
  • • No consumption of alcohol or drugs
  • • No use of corticosteroids or antidepressant medications
  • • No history of thyroid disorders, autoimmune diseases, cancer, or gastrointestinal diseases
  • Exclusion Criteria:
  • • Inability or unwillingness to continue with the study
  • • Pregnancy or Lactation
  • • Occurrence of any side effects

About National Nutrition And Food Technology Institute

The National Nutrition and Food Technology Institute is a leading research organization dedicated to advancing the fields of nutrition and food science through innovative clinical trials and studies. Committed to enhancing public health, the Institute focuses on developing evidence-based interventions and policies that address nutritional challenges and promote optimal dietary practices. With a multidisciplinary team of experts, the Institute collaborates with various stakeholders, including academic institutions, government agencies, and industry partners, to foster research excellence and translate findings into practical applications that benefit communities nationwide.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported